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Abstract
Purpose In some human fetuses undergoing prenatal
spina bifida repair, the skin defect is too large for primary
closure. The aim of this study was to engineer an autolo-
gous fetal skin analogue suitable for in utero skin recon-
struction during spina bifida repair.
Methods Keratinocytes (KC) and fibroblasts (FB) iso-
lated from skin biopsies of 90-day-old sheep fetuses were
cultured. Thereafter, plastically compressed collagen
hydrogels and fibrin gels containing FB were prepared. KC
were seeded onto these dermal constructs and allowed to
proliferate using different culture media. Constructs were
analyzed histologically and by immunohistochemistry and
compared to normal ovine fetal skin.
Results Development of a stratified epidermis covering
the entire surface of the collagen gel was observed. The
number of KC layers and degree of organization was
dependent on the cell culture media used. The collagen
hydrogels exhibited a strong tendency to shrink after eight
to ten days of culture in vitro. On fibrin gels, we did not
observe the formation of a physiologically organized
epidermis.
Conclusion Collagen-gel-based ovine fetal cell-derived
skin analogues with near normal anatomy can be engi-
neered in vitro and may be suitable for autologous fetal
transplantation.
Keywords Fetus  Spina bifida  Skin 
Tissue engineering  Fetal surgery
Introduction
Some congenital malformations go along with tissue
defects. Where the lack of tissue does not allow for primary
reconstruction, surgical correction becomes a true chal-
lenge. Large spina bifida lesions definitely belong to this
category. Spina bifida, a severe congenital malformation
affecting 1–2/1,000 life births, is characterized by an
extrusion of spinal cord and meninges through an open
defect of the spine, the adjacent soft tissue, and the skin.
The standard surgical repair of the defect ideally consists of
neural placode tubularization, dura closure, reinforcement
of the dura closure site with paraspinal myofascial flaps,
and finally skin closure. For many years, closure of the
defect has been performed shortly after birth. In cases of
large defects, rotational flaps, relief cuts, and skin trans-
plantations have been used to achieve soft tissue coverage.
Since publication of clear-cut benefits of prenatal versus
postnatal spina bifida repair by open fetal surgery (MOMS
Trial [1]), open in utero repair has become a new treatment
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option. Large defects during fetal repair, however, pose an
additional challenge, as tissue friability does not allow skin
closure under tension, and rotational flaps as used postna-
tally are considered too difficult and risky in the setting of
fetal surgery.
Hypothetically, an autologous, tissue-engineered fetal
dermo-epidermal skin substitute (fDESS) represents an
ideal approach to obtain a functional, watertight, and
definitive closure of the skin defect that, advantageously,
also enhances neural tissue protection.
The aim of this study was, therefore, the experimental
engineering of an autologous fetal skin analogue with the
prospect of a possible in utero application for skin recon-
struction during spina bifida repair.
Materials and methods
Cell cultures
For these experiments, stocks of cryopreserved fetal sheep
KC and FB were used. These cells had been isolated from
skin biopsies obtained in other experiments from time-
mated 90-day-old sheep fetuses (experiments approved by
the local authority of animal welfare). Prior to cryopreser-
vation, isolation had been performed as follows: The skin
biopsies were stored in DMEM (Gibco, Basel, Switzerland)
containing gentamycin 15 mg/ml (Gibco), Penicillin/
Streptomycin 300 U/ml, respectively, 300 lg/ml (Sigma,
Buchs, Switzerland), and Fungizone 250 ng/ml (Gibco) at
4 C before being processed in the first 24 h after harvest-
ing. For cell isolation, pieces were incubated for 1–2 h at
37 in 25 U/ml dispase (BD Biosciences, Allschwil, Swit-
zerland) in Ham’s F12 (Gibco) containing 5 ug/ml genta-
mycin. The epidermis was separated mechanically under
the microscope. Thereafter, the epidermis was digested in
prewarmed 0.5 % Trypsin/EDTA 10x (Gibco) for 2 min at
37 C to isolate KC. These were suspended in CnT-57
keratinocyte medium (CELLnTEC Advanced Cell Systems
AG, Bern, Switzerland) containing 5 lg/ml gentamycin,
then seeded in collagen type I-coated (calf hide collagen
from Symanthes, France) cell culture flasks (TRP, Swit-
zerland), expanded to confluence and then cryopreserved in
CnT-57 with 10 % DMSO (Sigma). The dermis was incu-
bated for about 45 min at 37, 5 % CO2, in 2 mg/ml col-
lagenase blend (Sigma), the hereby isolated FB were
resuspended in DMEM medium supplemented with 10 %
fetal calf serum (FCS), 4 mM L-alanyl-L-glutamine, 1 mM
sodium pyruvate, and 5 ug/ml gentamycin, seeded in cell
culture flasks and expanded. Cells were then cryopreserved
in supplemented DMEM with 10 % DMSO. After unth-
awing, KC were seeded and expanded in collagen-I-coated
flasks in CnT-57 containing 5 ug/ml gentamycin, FB in
culture flasks in supplemented DMEM.
Organotypic cultures with different media for in vitro
analysis
Collagen-based and fibrin-based dermo-epidermal skin
substitutes were prepared using a transwell system
(4.2 cm2 six-well cell culture inserts with membranes of
3.0 lm pore size from BD Falcon, Basel, Switzerland).
A first series of collagen-based gel were prepared as
follows: Per gel, 0.6 ml of chilled neutralization buffer
(containing 0.15 M NaOH, 0.32 M NaHCO3, 200 mM
Hepes), 0.4 ml of supplemented DMEM/10 % FCS con-
taining 50,000 of the cultured fetal sheep FB, and 2 ml calf
hide collagen I (Symanthes) were mixed and poured in the
insert. After approximately 4 h, the gels were compressed
as previously described by Braziulis [2]. These gels were
then cultured submersed in DMEM/10 % FCS for 7 days
before KC (200,000–400,000 per gel) were seeded on the
surface of each gel within siliconized polypropylene rings
of 15 mm diameter to avoid dispersion. The ring was
removed 4 h later. After the seeding, medium in the upper
and lower compartment of the transwell system was
changed to either CnT-09, CnT-FTAL-D (both from
CELLnTEC) or to modified Rheinwald and Green medium
(RGM; three parts of DMEM and one part of Ham’s F12,
5 mg/ml gentamycin, 1.4 mM CaCl2, 0.4 mg/ml hydro-
cortisone, 5 mg/ml 1 insulin, 2 nM triiodothyronine,
180 mM adenine, 10 ng ml/1 EGF (all from Invitrogen,
Basel, Switzerland), 0.1 nM choleratoxin [Calbiochem/
VWR International AG, Dietikon, Switzerland) and 10 %
lamb serum (LS) (from Gibco)]. Medium changes were
performed every 2–3 days. Eight days after KC seeding,
the gels were embedded for histological analysis.
For a second series of gels, slight modifications were
done. In an attempt to counteract previously observed con-
traction of collagen-based gels, the gels of these series were
combined with a reinforcement layer composed of IntegraTM
(Integra LifeScience, Plainsboro, NJ, USA) dermal template.
The template was bathed in DMEM/10 % LS and the
attached silicon membrane was detached mechanically.
500,000 FB suspended in DMEM/10 % lamb serum were
sucked in the dermal template using a sterile filter flask under
suction. Then, the IntegraTM dermal template was placed on
the membrane of the transwell insert, the collagen-gel
solutions was poured over it, and hours later, the construct
was compressed. In contrast to the first series of gels, the
submersion media used here before KC seeding (400,000 per
gel) was DMEM supplemented with 10 % LS instead of FCS
and after seeding, DMEM/10 % LS was used in the lower
compartment and CnT-09 in the upper compartment.
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Fibrin-based gels were produced with a volume of
1.5 ml. Fibrinogen from bovine plasma (Sigma) was
reconstituted in prewarmed NaCl to a final concentration of
10 mg/ml. 100,000 FB in DMEM were added to the filtered
solution and hold on ice. Then, 11 ll/ml Thrombin (Sigma,
100 U/ml) was added, and the mixture was quickly poured
in the insert. The gels were cultured submersed in DMEM/
10 % LS until KC seeding (200,000 per gel) and thereafter
in DMEM/10 % LS in the lower compartment and CnT-09
in the upper compartment.
Histology and immunofluorescence microscopy
The dermo-epidermal skin substitutes were embedded
eight days after KC seeding in OCT compound (Sakura
Finetek/Digitana AG, Horgen, Switzerland) and frozen to
-20 C. 10 lm cryosections of fDESS and of cryopre-
served skin biopsies of 90 and 120 days gestational age
(GA) were stained with hematoxylin and eosin (H&E,
Sigma) and imaged by light microscopy.
10 lm sections were also used for immunofluorescence
according to the protocol described by Pontiggia et al. [3].
Antibodies used to visualize components of epithelial cells
were K5 (clone GP5-2, 1:100, Progen, Germany), K10
(clone DE-K10; 1:100, Dako, Switzerland), K14 (clone
LL02, 1:50, Chemicon Switzerland), K15 (clone spm190,
1:50; Santa Cruz, Switzerland) and Loricrin (clone ab2472,
1:500, Abcam, Switzerland). Laminin 1&2 (clone ab7463,
1:500, Abcam) was used to visualize the basal membrane.
FITC-conjugated polyclonal immunoglobulins directed
to mouse, guinea pig, and rabbit were used as a secondary
antibodies, Hoechst 33342 (Sigma) for staining of nuclei.
Pictures of immunofluorescence staining were taken
with a DXM1200F digital camera connected to a Nikon
Eclipse TE2000-U inverted microscope. The device is
equipped with Hoechst 33342-, FITC-, and TRITC-filter
sets (Nikon AG, Switzerland; Software: Nikon NIS Ele-
ments 3.22.11). Images were processed with Adobe
Photoshop Elements 11.0 (Adobe Systems Inc., Germany).
Results
Analysis of dermo-epidermal skin substitutes cultivated
under different media
Development of an epidermal layer covering the entire
surface of the collagen gel was observed under all condi-
tions, but the number of KC layers and degree of organi-
zation was dependent on the media and the gel type used.
Under CnT-09 alone, the epidermis appeared to be more
regular and stratified, consisting of five to six intermediate
layers, and a thin stratum corneum (Fig. 1a, b). Formation
of a defined stratum basale was not completed yet eight
days after KC seeding. This epidermis showed some sim-
ilarity to fetal sheep skin at 90 days GA (Fig. 1g), partic-
ularly due to KC with large clear cytoplasma typically
found in fetal skin. Under CnT-FTAL-D, a strong differ-
entiation medium, the epidermis showed two to three layers
with no stratification, but already signs of cornification
(Fig. 1c). Under RGM/10 % LS, only one to two irregular
and already cornified layers could be observed. Further,
heaps of accumulated KC were spread over the whole
surface (Fig. 1d). In the collagen-based gel where CnT-09
Fig. 1 H&E staining, panels with same magnification, scale bar
50 lm. a–f Histological results of in vitro tissue-engineered dermo-
epidermal skin substitutes under different conditions; collagen-based
gels: a, b two different images of the same substitute cultured with
CnT-09, c substitute cultured with CnT-FTAL-D, d with supple-
mented RGM and e with CnT-09/supplemented DMEM. f Fibrin-
based gel cultured with CnT-09/supplemented DMEM. g, h Depict
fetal sheep skin at 90 and 120 days of gestation, respectively. Note
the resemblance of the epidermis in a and b with g fetal skin at
90 days of gestation. It contains the typical round cells with large and
clear cytoplasm typically seen in early fetal skin. In contrary,
e depicts an adult-type multilayered and stratified epidermis. a, b,
e Substitutes produced with CnT-09 alone or in combination with
supplemented DMEM yielded the best results
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was used in the upper compartment after KC seeding and
DMEM/10 % LS in the lower compartment, a stratified
epidermis of eight to ten layers developed (Fig. 1e),
strongly resembling tissue-engineered adult human dermo-
epidermal skin substitutes. On fibrin-based gels, a very
fragile monolayer, which usually ruptured during sample
preparation, could be observed (Fig. 1f).
The compressed collagen-gels showed good handling
properties and were felt to be stable enough to potentially
survive open intrauterine exposure, while fibrin gels were
too soft and fragile due to their predominantly aqueous
content.
All collagen-based gels demonstrated a strong tendency
to contract eight to ten days after gel production. The
combination of collagen-based gels with IntegraTM dermal
template reduced contraction, but rolling-in at the borders
occurred nonetheless. On the contrary, contraction was not
observed in fibrin-based gels. This was attributable to the
strong adherence of the fibrin gel to the insert membrane.
However, when the membrane was detached from the
insert, contraction occurred all the same.
Immunohistochemistry
All epithelial markers and the marker for the basal lamina
were expressed at 90 days as well as at 120 days GA
(Figs. 2, 3). The staining pattern followed the well-known
pattern usually found in human postnatal skin. K5
(Figs. 2a, 3a), K14 (Figs. 2c, 3c), and K15 (Figs. 2d, 3d)
were expressed in the basal epidermis, K10 (Figs. 2b, 3b)
in the suprabasal epidermis. At 90 days GA, the top layer
of the epidermis stained positive for Loricrin (Fig. 2e).
Whether this was specific periderm staining or unspecific
sebum staining was not identifiable. At 120 days GA, the
skin showed a distinct cornified layer with expression of
Loricrin in the stratum corneum as well as in the upper
intermediate layers (Fig. 3e). Laminin 1&2 stained the
basal membrane of epidermis and of vessels and hair fol-
licles within the dermis (Figs. 2f, 3f).
In the fDESS, K5 (Fig. 4a) and K14 (Fig. 4c) were
strongly positive throughout the whole epidermis. K10
(Fig. 4b) was only expressed in the suprabasal layers
whereas K15 was negative (Fig. 4d). Loricrin was detect-
able in the stratum corneum and in the uppermost inter-
mediate layers (Fig. 4e). There was a weak but continuous
staining for Laminin 1&2 (Fig. 4f), indicating deposition
of a basal lamina-like structure.
Discussion
This study demonstrates that collagen-gel based, ovine
fetal cell-derived skin analogues with near normal anatomy
can be engineered in vitro. We have chosen to use ovine
fetal cells in view of a future experimental in vivo autol-
ogous transplantation of such fDESS in the well-estab-
lished ovine spina bifida model [4]. Although here, we
have used fetal sheep cells, it is well conceivable that,
envisioning application in humans, an analogous human
fDESS can be engineered similarly, especially when con-
sidering that there is much more experience with human
rather than sheep tissue engineering of skin [5].
When examining different cell culture media and gel
types, collagen-based gels produced with CnT-09 yielded
Fig. 2 Immunohistochemical staining of fetal sheep skin at 90 days
of gestation. Scale bar 25 lm. The dashed line indicates the dermo-
epidermal junction. Markers (all in green) of the epidermal compart-
ment and of the basal membrane show the same pattern as seen in
human epidermis. a K5 is expressed mainly basally, b K10 supraba-
sally. c K14 and d K15 stain positive in the stratum basale, although
K15 is weak. e Positive Loricrin staining of the periderm in fetal skin
of 90 days gestational age is to be expected, here it remains unclear
whether this is a specific periderm staining or an unspecific sebum
staining. f Laminin 1&2 is clearly positive in the basal membrane of
the epidermis, vessels, and hair follicles
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the best results in the 3D culture. According to the man-
ufacturer, CnT-09 ‘‘allows efficient isolation and extended
in vitro culture of canine and ovine keratinocytes’’. We
noticed that in the 2D culture, CnT-09 induced differenti-
ation of the fetal ovine KC. Therefore, CnT-57, a prolif-
eration medium for human KC, was used for KC expansion
prior to seeding. Interestingly, the fDESS obtained with the
combination of CnT-09 and DMEM/10 % LS was clearly
different from fetal skin morphology seen at the GA of the
used cells (90 days) or at the expected chronological age
(105 days = 90 days GA ? 15 days substitute produc-
tion). The epidermis differentiated to an adult-type epi-
dermis consisting of several layers and a well-developed
stratum corneum. The same was observed by Bickenbach
and Holbrook [6] when culturing fetal skin in organ cul-
tures. They noticed that fetal epidermis differentiated from
three layers (basal, intermediate, and periderm) to an adult-
type epidermis consisting of a basal layer, two to three
spinous layers, one or two granular and several cornified
layers.
We analyzed the expression patterns of proteins indic-
ative for epidermal differentiation and homeostasis [7]. In
fetal sheep skin, marker patterns were similar to those seen
in human fetal and postnatal skin. In humans, K5 and K14
start to be expressed at 8 weeks GA, when the epidermis
consists of basal layer and periderm [8, 9]. In the normal
human homeostatic epidermis, K5 and K14 are expressed
in the basal layer and the first suprabasal layers. In wound
Fig. 3 Immunohistochemical staining of fetal sheep skin at 120 days
of gestation. Scale bar 25 lm. The dashed line indicates the dermo-
epidermal junction. The same staining pattern is seen as at 90 days of
gestation (Fig. 2). a K5 is expressed mainly basally and b K10
suprabasally. c K14 stains positive in the stratum basale. d Specific
staining of K15 is confined to the basal layer. The stratum corneum
shows unspecific staining. e Clear positive Loricrin staining of the
stratum corneum and the uppermost intermediate layers. f Expression
of Laminin 1&2 in the basal membrane of epidermis, vessels and hair
follicles
Fig. 4 Immunohistochemical staining of the dermo-epidermal skin
substitute cultured with CnT-09/supplemented DMEM (H&E in
Fig. 1e). The dashed line indicates the dermo-epidermal junction. All
markers are depicted in green. a K5 and c K14 are strongly positive
throughout the whole epidermis, indicating a ‘‘wound-like’’ situation
with non-established homeostasis. b K10 is being expressed in the
upper layers of the epidermis, indicating differentiation and stratifi-
cation. d The stratum corneum has stained unspecifically; K15 is
negative (as expected). e Loricrin is expressed in the granular and
cornified layers, signaling differentiation and stratification. f Laminin
1&2 indicates that a basal membrane has been deposited
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edges, however, expression of K5 and K14 can be induced
in migrating KC [10]. In our fDESS, K5 and K14 were
strongly expressed suprabasally, indicating a ‘‘wound-like’’
situation with non-established homeostasis.
K10, a differentiation marker found suprabasally in
postnatal human skin [10], is first induced between 9 and
10 weeks GA, when a third layer in between the stratum
basale and the periderm, the intermediate layer, is formed
[9]. We observed the same pattern in fetal sheep skin. In
fDESS, K10 was also expressed suprabasally, hence,
implying some degree of differentiation and stratification.
K15 is almost exclusively expressed in basal KC in a
homeostatic human epidermis. It, therefore, serves as a
dependable indicator for epidermal homeostasis [3]. It is
absent during wound healing [11, 12] and is not expressed
in dermo-epidermal skin equivalents before transplanta-
tion, but becomes upregulated in the stratum basale after
transplantation [3, 7]. K15 was expressed in fetal skin at 90
and 120 days GA, but, as expected, not in fDESS.
Periderm cells are unique to embryonic and fetal skin
and form the cornified cell envelope before keratinization
occurs at 160 days GA [13]. Loricrin is one of the major
precursor proteins of the cornified cell envelope and it is
restricted to the periderm [13]. It is expressed from the time
the three-layered epidermis is formed. After disappearance
of the periderm and appearance of interfollicular keratini-
zation, Loricrin is expressed in the granular and cornified
layers [13]. In our study, Loricrin was expressed in fetal
sheep skin and fDESS, again pointing out differentiation
and stratification of the tissue-engineered epidermis.
Clearly, the pattern seen in the fDESS was adultlike.
Laminin 1&2 stained positive in fDESS, demonstrating
that a continuous basal lamina-like structure to anchor the
epidermis was present. Taken together, there is convincing
evidence from fDESS histology and immunohistochemis-
try that a mature, although not completely homeostatic,
adultlike epidermis is formed in vitro. These findings are in
contrast to the work of Haake and Cooklis [14], where
under none of the conditions tested a mature epidermis was
formed. In their study, the epidermal equivalent remained
parakeratotic, and distribution patterns of K1 and K10
followed an aberrant organization with individual but dis-
persed stained cells in a disorganized epidermis. A possible
explanation for these different findings may be the different
culturing conditions and the different age of the fetal cells
used.
While fDESS consistency using compressed collagen-
based gels appeared ideal for surgical handling in utero, gel
contraction caused considerable size reduction and
increased thickness, thus representing a potentially severe
drawback in view of an application for spina bifida repair.
Interestingly, when using the same tissue engineering
protocol with human postnatal foreskin FB, contraction is
minimal. The positive effect of gel compression on sta-
bility and contraction in human collagen-gel-based skin
substitutes has been previously published by our group [2].
It can, therefore, be deduced that gel contraction in this
study is caused by the ovine fetal cells, particularly FB, as
contraction occurred also in control gels where KC seeding
was omitted. Haake and Cooklis [14] observed that fetal
FB contracted a dermal equivalent composed of rat tail
type I collagen to a greater extent than neonatal FB
(unpublished observation). But they also noticed contrac-
tion in fetal epidermis cultured on a neonatal dermal
equivalent. As explanation, they suggested a combination
of factors in the epidermis such as high level of fetal KC
migration over the dermal equivalent, localized prolifera-
tion, and apoptosis. In our series, contraction of the epi-
dermis on the dermal equivalent was not seen. The
epidermis always covered the whole gel.
The combination of collagen-based gels with IntegraTM
dermal template proved to reduce contraction. This can be
explicated by the fact that the dermal template itself cannot
loose volume and the collagen gel itself cannot retract from
the pores of the template it has solidified in. The contrac-
tion forces, however, led to a rolling-in of the borders.
The envisioned clinical application of tissue-engineered
autologous fetal skin is in utero repair of large spina bifida
lesions in human fetuses where primary skin closure is not
possible. Up to now, acellular dermal matrices such as
IntegraTM (Integra LifeScience, Plainsboro, NJ, USA) or
AlloDerm (LifeCellTM, Bridgewater, NJ, USA) have been
clinically used for skin defect coverage [15, 16]. Although
these non-viable scaffolds usually provide sufficient clo-
sure for the remainder of pregnancy, they are not optimal.
In case of IntegraTM, the silicon top layer guarantees
watertight coverage for at least several weeks before it is
detached from the underlying and now well-vascularized
neodermis that has gradually formed. But the silicon foil
apparently also hinders KC migration and thus the forma-
tion of an epidermis. Hence, these patients require soon
after birth at least a split thickness skin transplantation over
the IntegraTM-derived neodermis [15]. There is no specific
literature on outcomes after using AlloDerm. This prod-
uct has been used for skin closure in fetal spina bifida
repair in large series and has not compromised fetal repair
(MOMS trial), but complete epithelialization is not always
present at birth and additional wound management may be
necessary. In the best case scenario, fDESS would offer the
possibility of a single step, autologous, and thus definitive
in utero skin reconstruction. Obviously, a minute skin
biopsy would have to be harvested about three weeks
earlier, ideally when the obligatory diagnostic amniocen-
tesis is performed.
Hypothetically, fDESS could, under particular circum-
stances, also be used in the neonatal period, e.g., for
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postnatal repair of large spina bifida lesions (fDESS cul-
tured for prenatal repair that was finally not performed) or,
alternatively, as proposed by Fauza et al. [17], for other
indications such as large body wall defects. Last, gene-
modified tissue-engineered fetal skin could be made
available for newborns with genetic skin diseases, after
prenatal skin biopsy has confirmed the diagnosis and was
then used as cell source for culturing. Of note, fetal skin
biopsies are performed since many years for prenatal
diagnosis of genetic skin diseases [18].
In conclusion, this study provides evidence that colla-
gen-gel-based ovine fetal cell-derived skin analogues with
near normal cutaneous anatomy can be engineered in vitro.
This compelling progress raises the possibility of using
laboratory grown fetal skin during fetal surgery for spina
bifida to achieve autologous, instant, single step, and
definitive skin reconstruction in situations where primary
autochthonous skin closure is not possible.
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